Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1B | P28222 | 1/20 | 1.00 |
| ▸ | HTR2B | P41595 | 1/20 | 1.00 |
| ▸ | GPR65 | Q8IYL9 | 1/20 | 1.00 |
| ▸ | AURKA | O14965 | 1/20 | 0.44 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.44 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.44 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.44 |
| ▸ | CDK1 | P06493 | 1/20 | 0.42 |
| ▸ | CDK2 | P24941 | 1/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 6/20 | 0.38 |
| ▸ | HSP90AB1 | P08238 | 4/20 | 0.38 |
| ▸ | FEN1 | P39748 | 4/20 | 0.37 |
| ▸ | ALOX5AP | P20292 | 3/20 | 0.37 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.36 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.35 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.35 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29391421 | 1.00 | HTR1B (1.00) | HTR1BHTR2BGPR65AURKAPDPK1 | |
| SCHEMBL375979 | 1.00 | HTR1B (1.00) | HTR1BHTR2BGPR65AURKAPDPK1 | |
| Hydrochloric Acid SCHEMBL5746097 | 0.99 | HTR1B (0.97) | HTR1BHTR2BGPR65AURKAPDPK1 | |
| SCHEMBL8469545 | 0.99 | HTR1B (0.97) | HTR1BHTR2BGPR65AURKAPDPK1 | |
| SCHEMBL5749142 | 0.91 | HTR1B (0.84) | HTR1BHTR2BGPR65AURKAPDPK1 | |
| Fumaric Acid SCHEMBL5773986 | 0.89 | HTR1B (0.80) | HTR1BHTR2BGPR65AURKAPDPK1 | |
| Maleic Acid SCHEMBL5773984 | 0.89 | HTR1B (0.80) | HTR1BHTR2BGPR65AURKAPDPK1 | |
| SCHEMBL5749044 | 0.88 | HTR1B (0.78) | HTR1BHTR2BGPR65AURKAPDPK1 | |
| SCHEMBL5749623 | 0.88 | HTR1B (0.78) | HTR1BHTR2BGPR65AURKAPDPK1 | |
| Hydrochloric Acid SCHEMBL5748497 | 0.85 | HTR1B (0.74) | HTR1BHTR2BGPR65AURKAPDPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119614365-A | Continuous flow magnetic field biological fermentation and catalytic synthesis device and method | 英都斯特(无锡)感应科技有限公司 | 2025-03-14 | — | — | CN | claimed |
| CN-119549671-A | Electromagnetic treatment equipment and method for continuous casting and rolling of aluminum alloy | 内蒙古冶科电磁能科技有限公司 | 2025-03-04 | — | — | CN | claimed |
| US-20240408071-A1 | NOVEL COMBINATION OF SEROTONIN RECEPTOR (5-HTR2B) ANTAGONIST AND AN IMMUNOMODULATOR AND CHEMOTHERAPEUTIC DRUGS FOR INHIBITION OF CANCER | NATIONAL CENTRE FOR CELL SCIENCE (IN) | 2024-12-12 | — | — | US | claimed |
| EP-4408397-A1 | NOVEL COMBINATION OF SEROTONIN RECEPTOR (5-HTR) ANTAGONIST AND AN IMMUNOMODULATOR AND CHEMOTHERAPEUTIC DRUGS FOR INHIBITION OF CANCER | National Centre For Cell Science (IN) | 2024-08-07 | — | — | EP | claimed |
| CN-118080354-A | Novel roll grinding-dry grading-air flow suspension dry sorting method for iron-containing surrounding rock | 包钢集团矿山研究院（有限责任公司） | 2024-05-28 | — | — | CN | claimed |
| CN-118080163-A | Airflow suspension dry magnetic separation combined system suitable for recycling magnetic iron in iron-containing surrounding rock | 包钢集团矿山研究院（有限责任公司） | 2024-05-28 | — | — | CN | claimed |
| CN-118047504-A | Enhanced Fenton process for treating dimethyl sulfoxide-containing wastewater | 中复神鹰碳纤维股份有限公司 | 2024-05-17 | — | — | CN | claimed |
| CN-117672913-A | Process chamber, warming method thereof, semiconductor device and storage medium | 北京北方华创微电子装备有限公司 | 2024-03-08 | — | — | CN | claimed |
| CN-114807462-B | Method for hot rolling sludge by utilizing steel slag hot-disintegrating treatment | 马鞍山钢铁股份有限公司 | 2023-09-22 | — | — | CN | claimed |
| WO-2023053142-A1 | NOVEL COMBINATION OF SEROTONIN RECEPTOR (5-HTR2B) ANTAGONIST AND AN IMMUNOMODULATOR AND CHEMOTHERAPEUTIC DRUGS FOR INHIBITION OF CANCER | NATIONAL CENTRE FOR CELL SCIENCE (IN) | 2023-04-06 | — | — | WO | claimed |
| CN-115677500-A | Method for promoting high-efficiency synthesis of perfluoroketo ester by magnetically driving micro rotor | 扬州大学 | 2023-02-03 | — | — | CN | claimed |
| CN-114807462-A | Method for hot-rolling oil sludge through hot-disintegration treatment of steel slag | 马鞍山钢铁股份有限公司 | 2022-07-29 | — | — | CN | claimed |
| CN-115241034-B | Semiconductor processing method and semiconductor processing equipment | 北京北方华创微电子装备有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-12622234-B2 | Selective in-situ carbon-based mask protection | TOKYO ELECTRON LIMITED (JP) | 2026-05-05 | — | — | US | disclosed |
| US-20260085210-A1 | MULTILAYER COATING SYSTEMS OBTAINED FROM BLOCK COPOLYMER CONTAINING BASECOAT COMPOSITIONS | BASF COATINGS GMBH (DE) | 2026-03-26 | — | — | US | disclosed |
| US-20260053831-A1 | COMPOSITIONS AND METHODS FOR IMPROVING COGNITIVE FUNCTION | DIAMOND THERAPEUTICS INC (CA) | 2026-02-26 | — | — | US | disclosed |
| US-11274158-B2 | Methods and compositions for treating inflammatory or autoimmune diseases or conditions using calcitonin receptor activators | FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) | 2022-03-15 | — | — | US | disclosed |
| CN-110923707-B | Titanium alloy surface high-temperature-resistant composite coating material based on laser cladding | 中北大学 | 2022-03-11 | — | — | CN | disclosed |
| CN-114121798-A | Semiconductor structure and forming method thereof | 中芯国际集成电路制造(上海)有限公司 | 2022-03-01 | — | — | CN | disclosed |
| CN-114040767-A | Methods and compositions comprising 5HT receptor agonists for the treatment of psychological, cognitive, behavioral and/or emotional disorders | 钻石治疗公司 | 2022-02-11 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12622234-B2 | Selective in-situ carbon-based mask protection | CDH1, EPCAM, C9 | HTR1B 3756/4885HTR2B 3146/4885GPR65 3020/4885 |
| US-20260085210-A1 | MULTILAYER COATING SYSTEMS OBTAINED FROM BLOCK COPOLYMER CONTAINING BASECOAT COMPOSITIONS | B2M, PBRM1, F13B | HTR1B 1200/4885HTR2B 736/4885GPR65 2994/4885 |
| US-20260053831-A1 | COMPOSITIONS AND METHODS FOR IMPROVING COGNITIVE FUNCTION | HTR1B, HTR2B, HTR3B | HTR1B 1/4885HTR2B 2/4885GPR65 104/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.